GlassScriptPhysician profile
David I Freilich
NPI 1043307440
$14,619.73
in general payments reported to CMS, 2019-2025
46 companies · $1,788 in 2025
The $1,788 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,820 · 2020: $1,365 · 2021: $1,894 · 2022: $2,686 · 2023: $2,683 · 2024: $2,383 · 2025: $1,788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,839 · Consulting Fee: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,839.23 |
| Consulting Fee | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,605.89 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $1,326.62 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Novartis Pharmaceuticals Corporation | $1,146.28 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $861.78 | 2019-2024 | |
| Pfizer INC. | $828.79 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $818.42 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $733.22 | 2019-2024 | Xarelto |
| Amarin Pharma, INC. | $690.41 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $673.28 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $601.36 | 2021-2025 | Verquvo, Capvaxive |
| Arbor Pharmaceuticals, INC. | $494.86 | 2019-2021 | |
| Baxter Healthcare | $485.88 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Alnylam Pharmaceuticals INC. | $451.68 | 2020-2025 | Onpattro, Amvuttra |
| Kowa Pharmaceuticals America, INC. | $380.51 | 2019-2024 | Livalo |
| Novo Nordisk INC | $370.62 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $341.33 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $291.62 | 2019-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $276.25 | 2019-2024 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $263.77 | 2022-2025 | Assure Wcd |
| Esperion Therapeutics, INC. | $237.18 | 2020-2024 | Nexletol |
| Irhythm Technologies, INC. | $218.13 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Regeneron Healthcare Solutions, INC. | $150.57 | 2019-2021 | |
| Heartflow, INC. | $147.47 | 2022-2025 | Ffrct |
| Kiniksa Pharmaceuticals, LTD. | $145.76 | 2022-2023 | Arcalyst |
| Cvrx, INC. | $103.85 | 2024-2025 | Barostim Neo System |
| Philips North America LLC | $98.17 | 2024-2025 | (5044) Mcot, Extended Holter |
| Althera Pharmaceuticals LLC | $97.40 | 2021-2022 | |
| Biosense Webster, INC. | $82.77 | 2019-2023 | Carto 3 |
| Kiniksa Pharmaceuticals International, Plc | $77.44 | 2024 | Arcalyst |
| Abbott Laboratories | $72.48 | 2020-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Impulse Dynamics (USA) INC. | $71.46 | 2023-2024 | Optimizer, Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $66.25 | 2021-2025 | |
| Bardy Diagnostics, INC. | $54.00 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $48.60 | 2024 | Edarbi, Edarbyclor |
| Lilly USA, LLC | $48.49 | 2024-2025 | Zepbound, Jardiance |
| Lundbeck LLC | $45.31 | 2019-2021 | |
| Bridgebio Pharma, INC. | $36.56 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $29.04 | 2023-2024 | Inpefa |
| Medicure Pharma INC. | $23.24 | 2021 | |
| Inspire Medical Systems, INC. | $23.01 | 2023 | Inspire |
| Watermark Medical, INC. | $18.91 | 2024 | |
| Atricure, INC. | $18.76 | 2021 | |
| Genzyme Corporation | $17.14 | 2024 | |
| Abiomed | $16.39 | 2019 | |
| Glaxosmithkline, LLC. | $15.45 | 2025 | Shingrix, Arexvy |
| Amryt Pharma Holdings LTD | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Freilich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.